ACE Report Cover
SuperPath Approach for THA Improves Acute Pain & Function With Reduced Blood Loss & Hospital Stay
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
ARTHROPLASTY
SuperPath Approach for THA Improves Acute Pain & Function With Reduced Blood Loss & Hospital Stay .

Comparison of total hip arthroplasty with minimally invasive SuperPath approach vs. conventional posterolateral approach in elderly patients: A one-year follow-up randomized controlled research

Asian J Surg. 2021 Mar;44(3): 531-536.
Contributing Authors

X Li L Ma Q Wang K Rong

Ninety-six elderly patients (≥65 years old) diagnosed with either a femoral neck fracture or ischemic necrosis of femoral head who were scheduled for a total hip arthroplasty were randomized to receive either the supercapsular percutaneously-assisted total hip (SuperPath) approach (n=49) or the conventional posterolateral approach (n=47). Outcomes of interest included pain evaluated using the Visual Analogue Scale (VAS), hip function using the Harris Hip Score (HHS), C-reactive protein (CRP) levels, erythrocyte sedimentation rate (ESR), creatine phosphokinase (CK) levels, peri-operative blood loss, incision length, operative time, hospital length of stay, step length, stride speed and frequency. VAS and HHS scores were measured at 7 days, 1 month, 3 months, 6 months, and 1-year post-surgery. CRP, ESR, and CK levels were measured at 3 days post-surgery. Finally, step length, stride frequency, and stride speed were measured at 1 and 3 months post-surgery. Results demonstrated that incision length, hospital length of stay, mean blood loss were all statistically significantly reduced in the SuperPath approach group vs. the conventional group (p<0.001 for all); yet, the SuperPath approach took statistically significantly longer for operative time compared to the conventional approach (p<0.001). Furthermore, VAS and HHS scores were statistically significantly improved in the SuperPath group at 7 days and 1 month post-surgery, as well as 3 months post-surgery for HHS scores (p<0.05 for all). In addition, CRP and CK levels were statistically significantly lower in the SuperPath approach group compared to the conventional group at 3-days post-surgery (p<0.001 for both); ESR was similar between the two groups (p=0.515). Finally, step length and stride speed were statistically significantly improved in the SuperPath group at 7 days and 1 month post-intervention, but this did not extend to 3 months nor was this difference observed for stride frequency at any of the timepoints (p>0.05). Two cases of joint dislocation were observed in the conventional group while none were observed for the SuperPath group. The angles of abduction were also statistically significantly lower in the SuperPath group (p<0.05), but no statistical significant difference was observed for the angle of anteversion between the 2 groups (p>0.05).

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. SuperPath Approach for THA Improves Acute Pain & Function With Reduced Blood Loss & Hospital Stay. ACE Report. 2021;18(1):1. Available from: https://myorthoevidence.com/AceReport/Show/superpath-approach-for-tha-improves-acute-pain-function-with-reduced-blood-loss-hospital-stay

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report